Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes

• References

• 1 Djulbegovic B. Lack of prophylactic anticoagulant therapy is not associated with clinical thrombotic complications in patients with hemophilia who undergo orthopedic surgical procedures. Am J Hematol. 1995; 229-30.
• 2 Ritchie B, Woodman RC, Poon MC. Deep venous thrombosis in hemophilia A. Am J Med 1992; 93: 699-700.
• 3 Kasper CK. Postoperative thrombosis in hemophilia B. Ν Engl J Med 1973; 289: 160.
• 4 Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Med-icine (Baltimore) 1983; 62: 248-55.
• 5 Casares PZ, Gillet DS, Verity DH. et al. Bilateral simultaneous central retinal vein occlusion (crvo) caused by Waldenstrom's macroglobulinemia with acquired von Willebrand's disease. Br J Haematol 2002; 118: 344-7.
• 6 Bowen D, Dasani H, Yung B. et al A deep venous thrombosis and pulmonary embolism in a patient with type III von Willebrand's disease, protein C and antithrombin III deficiency. Br J Haematol 1992; 81: 446-7.
• 7 Keijzer MB, den Heijer M, Blom HJ. et al Interaction between hyperhomocysteinemia, mutated methylenetetrahyfrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002; 88: 723-8.
• 8 Harrington DJ, Malefora A, Schmeleva V. et al Genetic variations observed in arterial and venous thromboembolism-relevance for therapy, risk prevention and prognosis. Clin Chem Lab Med 2003; 41: 496-500.